Retour
Fourchette du Jour
11,42 €
12,12 €
Fourchette 52 Semaines
5,28 €
21,73 €
Volume
3 806 100
Moyenne 50J / 200J
13,42 €
/
10,12 €
Clôture Précédente
11,76 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -10,7 | 0,4 |
| P/B | 4,2 | 2,9 |
| ROE % | -55,6 | 3,8 |
| Net Margin % | -478,3 | 3,9 |
| Rev Growth 5Y % | 1,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
32,50 €
+179.7%
Low: 26,00 €
High: 50,00 €
BPA Prévisionnel
-1,33 €
CA Est.
37 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,16 €
0,32 € – 2,21 €
|
660 M | 4 |
| FY2029 |
-0,44 €
-0,84 € – -0,12 €
|
290 M | 4 |
| FY2028 |
-1,31 €
-2,81 € – 0,19 €
|
150 M | 10 |
Points Clés
Revenue grew 1,06% annually over 5 years — modest growth
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -187,49M
Revenue growth is decelerating — 1Y growth trails 5Y average by 61,61%
Capital efficient — spends only 1,68% of revenue on capex
Croissance
Revenue Growth (5Y)
1,06%
Revenue (1Y)-60,55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-55,56%
ROIC-29,69%
Net Margin-478,33%
Op. Margin-504,09%
Sécurité
Debt / Equity
0,03
Current Ratio6,47
Interest Coverage0,00
Valorisation
P/E Ratio
-10,70
P/B Ratio4,16
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -60,55% | Revenue Growth (3Y) | -38,59% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1,06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 42,73M | Net Income (TTM) | -204,38M |
| ROE | -55,56% | ROA | -32,01% |
| Gross Margin | 79,28% | Operating Margin | -504,09% |
| Net Margin | -478,33% | Free Cash Flow (TTM) | -187,49M |
| ROIC | -29,69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 6,47 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,70 | P/B Ratio | 4,16 |
| P/S Ratio | 51,20 | PEG Ratio | -0,19 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,19B | Enterprise Value | 1,60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 42,73M | 108,30M | 113,31M | 3,65M | 40,96M |
| Net Income | -204,38M | -97,01M | -57,51M | -161,82M | -122,25M |
| EPS (Diluted) | -1,21 | -0,70 | -0,54 | -2,05 | -2,36 |
| Gross Profit | 33,88M | 108,30M | 113,31M | 3,65M | 40,96M |
| Operating Income | -215,38M | -110,40M | -68,00M | -162,72M | -127,02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 638,50M | 352,21M | 274,95M | 146,39M | 207,01M |
| Total Liabilities | 112,27M | 142,69M | 235,32M | 191,48M | 174,51M |
| Shareholders' Equity | 526,23M | 209,52M | 39,63M | -45,09M | 32,50M |
| Total Debt | 17,77M | 25,40M | 32,12M | 37,61M | 29,92M |
| Cash & Equivalents | 602,07M | 302,08M | 200,35M | 88,50M | 150,56M |
| Current Assets | 614,81M | 320,39M | 235,37M | 98,54M | 162,56M |
| Current Liabilities | 95,07M | 110,95M | 186,44M | 71,52M | 64,20M |